We showed that Akt-activated ECs (E4 + EC) create a pro-tumoral niche through contact-mediated or secreted factors in models such as lymphatic, breast and ovarian cancer [13,14,15,16,17,18,19,20,21]. Here, AKT1 is linked to ovarian carcinoma.